Keywords: آنتاگونیست گیرنده لوکوترین; Bronchiolitis; Chest imaging; Leukotriene receptor antagonist; Multisystemic syndrome; Small airway disease;
مقالات ISI آنتاگونیست گیرنده لوکوترین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتاگونیست گیرنده لوکوترین; Intermittent therapy; Patient centered treatment; Adherence; Qualitative study; ICS; inhaled corticosteroids; SBA; symptom based adjustment; LTRA; leukotriene receptor antagonist; LABA; long acting beta agonist;
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Allergic asthma; Elderly; Aeroallergens; Atopy; IgE; Asthma-COPD overlap syndrome (ACOS); Age of asthma onset; ACOS; Asthma-COPD overlap syndrome; AERD; Aspirin-exacerbated respiratory disease; BMI; Body mass index; COPD; Chronic obstructive pulmo
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; overweight; obesity; children; infants; exacerbation; AD; Asthma symptom days; BMI; Body mass index; ED; Emergency department; ICS; Inhaled corticosteroids; INFANT; Individualized Therapy for Asthma in Toddlers; LTRA; Leukotriene receptor antagoni
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; obesity; inhaled corticosteroid monotherapy; inhaled corticosteroid combination therapy; marginal structural Cox model; BMI; Body mass index; HFA-BDPeq; Hydrofluroalkane-propelled beclomethasone dipropionate or equivalent; HR; Hazard ratio; ICD-9/
Keywords: آنتاگونیست گیرنده لوکوترین; Severe asthma; Severe recurrent wheeze phenotypes; Children; Bacterial infection; Gastroesophageal reflux; Multiple allergies; BMI; Body mass index; FP; Fluticasone propionate; GERD; Gastroesophageal reflux; ICS; Inhaled corticosteroid; LTRA; Leukotriene
Keywords: آنتاگونیست گیرنده لوکوترین; Exhaled nitric oxide; blood eosinophil count; asthma control; lung function; bronchial responsiveness; ACT; Asthma Control Test; ATS; American Thoracic Society; BHR; Bronchial hyperresponsiveness; Feno; Fraction of exhaled nitric oxide; FVC; Forced vital
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; asthma treatment; asthma biomarkers; asthma phenotype; inhaled corticosteroid; leukotriene receptor antagonist; personalized medicine; treatment response; ACD; Asthma control day; ECP; Eosinophil cationic protein; ICS; Inhaled corticosteroid; INFA
Keywords: آنتاگونیست گیرنده لوکوترین; AED; Accident and Emergency Department; aYPFS; augmented Yu Ping Feng San; ACT; Asthma Control Test; cACT; Childhood Asthma Control Test; CAM; complementary and alternative medicines; FEF50; forced expiratory flow at 50% of FVC; FEV1; forced expiratory vo
Keywords: آنتاگونیست گیرنده لوکوترین; Chronic urticaria; Hives; Patient-specific clinical characteristics; Treatment selection; Control; Physical urticaria; Dermatographism; Medications; CU; Chronic urticaria; JTFPP; Joint Task Force Practice Parameter; LTRA; Leukotriene receptor antagonist;
Keywords: آنتاگونیست گیرنده لوکوترین; Omalizumab; Urticaria; Chronic spontaneous; Chronic idiopathic; Itch; Hive; Pruritus; Wheal; Antihistamine; AE; Adverse event; CI; Confidence interval; CIU; Chronic idiopathic urticaria; CSU; Chronic spontaneous urticaria; CU; Chronic urticaria; DLQI; Der
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; asthma control; quality of life; network meta-analysis; questionnaire; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist;
Keywords: آنتاگونیست گیرنده لوکوترین; Airway remodeling; asthma; asthma control; asthma exacerbations; early intervention in asthma; biomarkers; environment; genetics; inhaled corticosteroids; leukotriene receptor antagonists; long-acting β-adrenergic agonists; personalized medicine; severe
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Lung function; Macrolide; Meta-analysis; CNKI; China national knowledge internet; WMD; weighed mean difference; SMD; standardized mean difference; PEF; peak expiratory flow; AHR; airway hyper-responsiveness; FEV1/FVC; the ratio of forced expirator
Keywords: آنتاگونیست گیرنده لوکوترین; asthma; fixed-dose combination inhaler; leukotriene receptor antagonist; long-acting β2-agonist; prescription patterns;
Keywords: آنتاگونیست گیرنده لوکوترین; ADAM; A Disintegrin And Metalloprotease Domain; AHR; airway hyperreponsiveness; Ang; angiopoietin; ASM; airway smooth muscle; BALf; bronchoalveolar lavage fluid; bFGF; basic fibroblast growth factor; BM; basement membrane; Col; collagen; CTGF; connective
Keywords: آنتاگونیست گیرنده لوکوترین; ED; Emergency department; HEDIS; Healthcare Effectiveness Data and Information Set; ICD-9; International Classification of Diseases, 9th revision; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; LTRAM; Leukotriene receptor antagonist m
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Anti-asthmatic agents; Step down; Withdraw; Discontinue; Decrease; Wean; Cessation; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; RCT; Randomized controlled trial;
Keywords: آنتاگونیست گیرنده لوکوترین; Pediatrics; Asthma; Physician training; Inhaled corticosteroids; Spirometry; %FEV1; Percentage predicted FEV1; BMI; Body mass index; CT; Computed tomography; CXR; Chest radiography; ED; Emergency department; FVC; Forced vital capacity; GERD; Gastroesophag
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Comparative effectiveness; Retrospective cohort study; Inhaled corticosteroids; Long-acting β2-adrenergic agonist; short-acting β2-adrenergic-agonists; Budesonide-formoterol combination; Fluticasone-salmeterol combination; BFC; Budesonide-form
Keywords: آنتاگونیست گیرنده لوکوترین; Chronic idiopathic urticaria; chronic spontaneous urticaria; H1-antihistamine; H2-antihistamines; hive; itch; leukotriene receptor antagonist; omalizumab; pruritus; wheal; AE; Adverse event; CIU/CSU; Chronic idiopathic urticaria/chronic spontaneous urtica
Keywords: آنتاگونیست گیرنده لوکوترین; AA; arachidonic acid; COX; cyclooxygenase; EDTA; ethylenediaminetetraacetate; ESI; electrospray ionization; fMLP; formyl-methionyl-leucyl-phenylalanine; 12-HHT; 12(S)-hydroxy-5-cis-8,10-trans-heptadecatrienoic acid; 5-H(P)ETE; 5(S)-hydro(pero)xy-6-trans-8
Keywords: آنتاگونیست گیرنده لوکوترین; Montelukast; smoking; fluticasone propionate; leukotriene receptor antagonist; asthma control; corticosteroids; AE; Adverse experience; COPD; Chronic obstructive pulmonary disease; FVC; Forced vital capacity; PEF; Peak expiratory flow; SABA; Short-acting
Potential role of leukotriene receptor antagonists in reducing cardiovascular and cerbrovascular risk: A systematic review of human clinical trials and in vivo animal studies
Keywords: آنتاگونیست گیرنده لوکوترین; AA; arachidonic acid; CV; Cardiovascular; CysLTs; cysteinyl leukotrienes; CysLTR; cysteinyl leukotrienes receptor; LT; leukotrienes; LTRA; leukotrienes receptor antagonist; Leukotriene receptor antagonist; Montelukast; Cardiovascular event; Cysteinyl leuk
The Tempest: Difficult to Control Asthma in Adolescence
Keywords: آنتاگونیست گیرنده لوکوترین; Severe asthma; Adolescent; Phenotype; Biologics; Difficult-to-treat asthma; Adherence; Psychosocial; ACT; Asthma Control Test; ATS; American Thoracic Society; BT; bronchial thermoplasty; ERS; European Respiratory Society; FDA; Food and Drug Administration
Leukotriene receptor antagonist attenuated airway inflammation and hyperresponsiveness in a double-stranded RNA-induced asthma exacerbation model
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Cysteinyl leukotrienes; Double-stranded RNA; Leukotriene receptor antagonist; Virus; Ach; acetylcholine; AHR; airway hyperresponsiveness; ASM; airway smooth muscle; BAL; bronchoalveolar lavage; BALF; bronchoalveolar lavage fluid; CCL; Chemokine (C
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Child; Inhaled corticosteroid; Long-acting β-agonist; Step-up therapy; aOR; Adjusted odds ratio; aRR; Adjusted rate ratio; BDP; Beclomethasone dipropionate; BTS/SIGN; The British Thoracic Society and Scottish Intercollegiate Guidelines Network; C
The role of cysteinyl leukotrienes and their receptors in refractory nasal polyps
Keywords: آنتاگونیست گیرنده لوکوترین; CRSw/sNP; chronic rhinosinusitis with/without nasal polyp; IL; interleukin; KCN; key cytokines negative; CysLT; cysteinyl leukotriene; CYSLTR; cysteinyl leukotriene receptor; LTRA; leukotriene receptor antagonist; FESS; functional endoscopic sinus surgery
A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma
Keywords: آنتاگونیست گیرنده لوکوترین; Anticholinergic drug; asthma; asthma control; children; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-IA; Interviewer-administered Asthma Control Questionnaire; FEF25-75; Forced expiratory flow at 25% to 75% of the forced vital capacity
Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment
Keywords: آنتاگونیست گیرنده لوکوترین; Adrenergic receptors; asthma; child; disease exacerbation; therapeutics; ADRB2; β2-Adrenoceptor gene; GALA II; Genes-Environments and Admixture in Latino Americans; HWE; Hardy-Weinberg equilibrium; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonis
Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?
Keywords: آنتاگونیست گیرنده لوکوترین; Allergic rhinitis; Oral antihistamine; Intranasal antihistamine; Intranasal corticosteroid; Leukotriene receptor antagonist; Minimal clinically important difference (MCID); Seasonal allergic rhinitis (SAR); Total nasal symptom score (TNSS); AHRQ; Agency f
Tiotropium add-on therapy in adolescents with moderate asthma: AÂ 1-year randomized controlled trial
Keywords: آنتاگونیست گیرنده لوکوترین; Adolescent; anticholinergic drug; asthma; asthma control; efficacy; FEV1; lung function; Respimat; safety; tiotropium; ACQ-6; 6-question Asthma Control Questionnaire; ACQ-7; 7-question Asthma Control Questionnaire; AQLQ(S)+12; Asthma Quality of Life Quest
Phenotypic and genotypic association of epithelial IL1RL1Â to human TH2-like asthma
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; IL1RL1; ST2L; sST2; TH2 inflammation; single nucleotide polymorphisms; AEC; 3-Amino-9-ethylcarbazole; ALI; Air-liquid interface; ATS; American Thoracic Society; BAL; Bronchoalveolar lavage; BMI; Body mass index; CLCA1; Calcium-activated chloride c
Alternatives à la corticothérapie inhalée dans le traitement de l’asthme de l’enfant : les anti-leucotriènes
Keywords: آنتاگونیست گیرنده لوکوترین; Asthme; Enfant; Montélukast; Anti-leucotriènesAsthma; Children; Therapy; Leukotriene receptor antagonist; Long-acting bronchodilator
Leukotriene D4 and methacholine bronchial provocation tests for identifying leukotriene-responsiveness subtypes
Keywords: آنتاگونیست گیرنده لوکوترین; Leukotriene D4; methacholine; bronchial provocation test; asthma; leukotriene responsive; leukotriene unresponsive; control status; AUC; Area under the curve; FVC; Forced vital capacity; ICS; Inhaled corticosteroid; LTD4; Leukotriene D4; LTD4-BPT; LTD4 br
Antineutrophil cytoplasmic autoantibodies and myeloperoxidase autoantibodies in clinical expression of Churg-Strauss syndrome
Keywords: آنتاگونیست گیرنده لوکوترین; Antineutrophil cytoplasmic autoantibodies; Churg-Strauss syndrome; clinical features; US Food and Drug Administration's Adverse Event Reporting System database; myeloperoxidase; AERS; Adverse Event Reporting System; ANCA; Antineutrophil cytoplasmic autoan
Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
Keywords: آنتاگونیست گیرنده لوکوترین; Atherosclerosis; inflammation; myocardial infarction; pharmacoepidemiology; stroke; ACE; Angiotensin-converting enzyme; ATC; Anatomical Therapeutical Chemical; COPD; Chronic obstructive pulmonary disease; CysLT; Cysteinyl leukotriene; HR; Hazard ratio; IC
Leukotrienes and airway inflammation
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; Cysteinyl leukotriene; Leukotriene receptor antagonist; 5-Lipoxygenase; Leukotriene B4
Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy
Keywords: آنتاگونیست گیرنده لوکوترین; CAMP; Childhood Asthma Management Program; EPR-3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; mAPI; Modified Asthma Predictive Index;
(Ex-)smoking asthma patients in general and specialized Belgian practice
Keywords: آنتاگونیست گیرنده لوکوترین; Non-smoking asthma patients; (Ex-)smoking asthma patients; COPD; Asthma; ANS; non-smoking asthma patients; AS; (ex-)smoking asthma patient; COPD; chronic obstructive pulmonary disease; FCT; fixed combination treatment; GINA; global initiative for asthma;
Efficacy of montelukast, a leukotriene receptor antagonist, for the treatment of dysmenorrhea: A prospective, double-blind, randomized, placebo-controlled study
Keywords: آنتاگونیست گیرنده لوکوترین; Dysmenorrhea; Leukotriene receptor antagonist; Montelukast; NSAID
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma
Keywords: آنتاگونیست گیرنده لوکوترین; Intravenous montelukast; acute asthma; asthma exacerbation; FEV1; hospitalization; leukotriene receptor antagonist; randomized trialAE, Adverse experience; LS, Least squares; OR, Odds ratio
Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: The MONtelukast In Chronic Asthma (MONICA) study
Keywords: آنتاگونیست گیرنده لوکوترین; Montelukast; Asthma therapy; Add-on therapy; Leukotriene receptor antagonist
Eoxins: AÂ new inflammatory pathway in childhood asthma
Keywords: آنتاگونیست گیرنده لوکوترین; Exhaled breath condensate; leukotrienes; 15-hydroxyeicosatetraenoic acid; eoxins; asthma; child; BAL; Bronchoalveolar lavage; BHR; Bronchial hyperresponsiveness; BMI; Body mass index; CysLT; Cysteinyl leukotriene; EBC; Exhaled breath condensate; ECP; Eosi
Advances in the management of asthma
Keywords: آنتاگونیست گیرنده لوکوترین; adherence; atopy; beta agonist; inhaled corticosteroid; leukotriene receptor antagonist; macrolide; prednisolone; viral infection; wheeze
Effect of azelastine, montelukast, and their combination on allergen-induced bronchoconstriction in asthma
Keywords: آنتاگونیست گیرنده لوکوترین; Anti-histamine; Leukotriene receptor antagonist; Bronchial allergen response; Early phase response; Late phase response; Bronchoprotection;
The effect of the leukotriene receptor antagonist zafirlukast on neurokinin A-induced bronchoconstriction in patients with asthma—A comparison with leukotriene D4 induced broncoconstriction
Keywords: آنتاگونیست گیرنده لوکوترین; Leukotriene receptor antagonist; Leukotrienes; Neuropeptides; Neurokinin A; Bronchoconstriction; Asthma
Azithromycin or montelukast as inhaled corticosteroid-sparing agents in moderate-to-severe childhood asthma study
Keywords: آنتاگونیست گیرنده لوکوترین; Asthma; moderate to severe; children; macrolide; leukotriene receptor antagonist; clinical trial; CARE; Childhood Asthma Research and Education; DSMB; Data Safety Monitoring Board; ICS; Inhaled corticosteroid; MARS; Montelukast or Azithromycin for Reducti
Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing
Keywords: آنتاگونیست گیرنده لوکوترین; Wheezing; preschool children; montelukast; budesonide; API; Asthma predictive index; AUC; Area under the curve; CARE; Childhood Asthma Research and Education; EFD; Episode-free day; ICS; Inhaled corticosteroid; LTRA; Leukotriene receptor antagonist; RTI;
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation
Keywords: آنتاگونیست گیرنده لوکوترین; Anti-inflammatory effects; anti-IgE; asthma; atopic dermatitis; β2-agonist; eosinophilic inflammation; inflammatory mediators; inhaled corticosteroids; leukotriene receptor antagonist; paradigm shift; small airways; systemic inflammation; rhinitis; Cys-L